Immunotherapy: Recurrent and/or metastatic head and neck cancer portends a poor prognosis with traditional treatments, but current immunotherapy with immune checkpoint inhibitors has the potential to improve these clinical outcomes. This review focuses on the major breakthroughs that have led to the current understanding of immunotherapy in head and neck cancer as well as the future direction of the field. Ultimately, this understanding will guide clinicians on the selection of patients with head and neck cancer and practical considerations before starting immunotherapy.
http://ift.tt/2uzxiwD
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Πέμπτη 27 Ιουλίου 2017
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Evaluation of the effect of three mouthwashes on the mechanical properties and surface morphology of several orthodontic wires: An in vitro ...
-
AtmosphereAtmosphere, Vol. 11, Pages 932: Last ... The New England Journal of Medicine: Cancer, Ge... Analytical Chemistry[ASAP] Cel...
-
Abstract Background Drug-related problems are mostly preventable or predictable circumstances that may impact on health outcomes. Clinica...
-
Alternative Techniques in Özgür Sürmelioğlu 1 , Süleyman Özdemir 1 , Özgür Tarkan 1 , Ülkü Tuncer 1 , Fikret Çet...
-
Cancers, Vol. 9, Pages 92: Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy : Cancers, Vol. 9, Pages 92: Re...
-
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182, A case of occult bilateral optic nerve...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου